# FDA Approves J&J Dual Energy Catheter for Cardiac Ablation

> fda · REPORTED · 2026-07-08

The FDA approved Johnson & Johnson's dual energy catheter for cardiac ablation procedures on July 8, 2026, marking another regulatory win for J&J's cardiovascular unit, whose sales rose 13% to $2.38 billion in Q1 2026.

About Johnson & Johnson: Johnson & Johnson is a global medtech and pharmaceutical company whose cardiovascular division develops and markets ablation systems, electrophysiology tools, and related devices for treating heart rhythm disorders.

- Company: Johnson & Johnson
- Sector: medical devices
- Primary source: https://www.mddionline.com/latest-news

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.